Fig. 4.
Boxplots of the duration of filler in situ and the volume of filler in patients who did and did not develop the posthyalase syndrome. A, Patients with a posthyaluronidase syndrome (true) were associated with significantly longer duration of filler in situ than patients who did not report a posthyaluronidase syndrome (false; P = 0.00019). B, Patients with a posthyaluronidase syndrome (true) were associated with significantly higher volume of filler than patients who did not report a posthyaluronidase syndrome (false; P = 0.000017).
